RC
AGN

RegentAtlantic Capital’s Allergan plc AGN Stock Holding History

RegentAtlantic Capital’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-5,958
Closed -$1.05M – 491
2020
Q1 		$1.05M Sell
5,958
-3,346
-36% -$630K 0.08% 197
2019
Q4 		$1.78M Sell
9,304
-248
-3% -$44.7K 0.11% 181
2019
Q3 		$1.61M Sell
9,552
-1,924
-17% -$313K 0.11% 185
2019
Q2 		$1.92M Sell
11,476
-569
-5% -$78.8K 0.13% 166
2019
Q1 		$1.76M Sell
12,045
-488
-4% -$70.8K 0.12% 168
2018
Q4 		$1.68M Buy
12,533
+803
+7% +$132K 0.14% 163
2018
Q3 		$2.23M Buy
11,730
+262
+2% +$48.1K 0.17% 146
2018
Q2 		$1.91M Sell
11,468
-247
-2% -$39.7K 0.16% 145
2018
Q1 		$1.97M Sell
11,715
-1,035
-8% -$174K 0.16% 145
2017
Q4 		$2.09M Sell
12,750
-1,353
-10% -$243K 0.17% 142
2017
Q3 		$2.89M Sell
14,103
-509
-3% -$118K 0.25% 114
2017
Q2 		$3.55M Sell
14,612
-14
-0.1% -$3.29K 0.32% 83
2017
Q1 		$3.49M Sell
14,626
-2,121
-13% -$494K 0.32% 82
2016
Q4 		$3.52M Buy
16,747
+307
+2% +$63.6K 0.34% 77
2016
Q3 		$3.79M Sell
16,440
-59
-0.4% -$14.4K 0.39% 69
2016
Q2 		$3.81M Buy
16,499
+7,107
+76% +$1.64M 0.37% 69
2016
Q1 		$2.52M Sell
9,392
-259
-3% -$74.1K 0.28% 91
2015
Q4 		$3.02M Buy
9,651
+96
+1% +$28.6K 0.32% 86
2015
Q3 		$2.6M Sell
9,555
-470
-5% -$144K 0.25% 100
2015
Q2 		$3.04M Buy
+10,025
New +$2.99M 0.27% 95
2013
Q3 		– Sell
-8,601
Closed -$1.09M – 348
2013
Q2 		$1.09M Buy
+8,601
New +$974K 0.13% 145

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

RegentAtlantic Capital's AGN Position: Q2 2020 in Review

RegentAtlantic Capital sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 5,958 shares — an estimated $1.05M sold.

RegentAtlantic Capital first reported a position in AGN in Q2 2013 and held it in 21 quarters. The position peaked at $3.81M in Q2 2016. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • RegentAtlantic Capital reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • RegentAtlantic Capital sold 5,958 Allergan plc shares in Q2 2020, an estimated $1.05M.
  • RegentAtlantic Capital first reported a position in Allergan plc in Q2 2013 and held it in 21 quarters.
  • RegentAtlantic Capital's Allergan plc position peaked at $3.81M in Q2 2016.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on RegentAtlantic Capital's 13F filing for Q2 2020, filed 13 Aug 2020.